medRxiv PreprintsInternational16 November 2026
Facial Emotion Processing and GABAergic Modulation in Individuals at Clinical High-Risk for Psychosis
This is an official announcement record
Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.
Deficits in social cognition, including facial emotion recognition (FER), are present in individuals at clinical high-risk for psychosis (CHR-P). Altered GABAergic and glutamatergic signalling within corticolimbic circuitry has been proposed to underlie FER deficits in psychosis. We investigated FER performance and brain activation in CHR-P individuals, and whether pharmacological enhancement of GABAergic signalling with diazepam modulates these processes. In Study 1, 24 antipsychotic-naive CHR-P individuals and 24 healthy controls underwent fMRI while performing the Penn Emotion Recognition T
Read the official announcement
Opens www.medrxiv.org
More from medRxiv Preprints
- Unmet needs of Polish patients with cystic fibrosis seen through the lens of crowdfunding20 November 2026
- Motherly Plus: Study Protocol of a Randomized Controlled Trial Evaluating a Smartphone-Assisted Single-Session Psychotherapy Intervention for Postpartum Depression20 November 2026
- Targeting memory consolidation in major depression via pharmacological slow-wave sleep promotion20 November 2026
- Epidemiology of Cardiac Structure and Function Among African Caribbeans in Tobago: A Population-based Cohort Study20 November 2026
- Depressive Symptom Trajectories and Incident Cognitive Impairment by Outcome Ascertainment20 November 2026
This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.